Search
 

Pfizer/Wyeth Merger May Cut Space Needs

NEW YORK CITY-The New York City-based Pfizer is already looking to reduce its square footage by 15% globally.

By Paul Bubny | Updated on January 26, 2009

NEW YORK CITY-The $68-billion deal between pharmaceutical giants Pfizer and Wyeth may or may not create a hugely successful combination, and may or may not lead to a wave of further consolidation among drug manufacturers. What is certain is that the combined company will carry forth with a smaller real estate footprint.

In announcing its acquisition of rival Wyeth–based on the other side of the Hudson River in Madison, NJ–Pfizer on Monday also provided details of a new cost-reduction initiative. As part of the initiative, Pfizer says it will reduce its global workforce by approximately 10%, or approximately 8,000 jobs. Reductions will span sales, manufacturing, research and development and administrative organizations, Pfizer states.

The company also intends to reduce the number of manufacturing sites from the current 46 to 41, as well as reduce its facilities square footage by approximately 15%, according to a release. During a news conference Monday at Pfizer’s world headquarters, 235 E. 42nd St., Pfizer officials declined to identify where plant closings would occur, and a Pfizer spokesman did not respond to GlobeSt.com’s requests for further comment.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.